Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Citrate Anticoagulation for CRRT During Veno-venous ECMO
NCT05148026Completed
- Sponsor
- University of Milano-Bicocca
- Start
- Nov 2021
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of trisodium citrate in acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) (2 arms), sponsored by University of Milano-Bicocca. Primary endpoint: Incidence of CRRT circuit clotting at 72 hours. Started Nov 2021; status: completed.
02
Drugs
trisodium citrate
03
Conditions
acute kidney injury (AKI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT05148026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05148026.